NCT05443854 2022-07-05
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
Clinical Trials
3 trialsNCT00735813 2012-09-05
Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia
Aarhus University Hospital
Phase 3 Completed
NCT00001338 2008-03-04
A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase 3 Completed